Drug recall · October 3, 2018
Fenofibrate Tablets recall
Why: Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90
- Lots / codes
Lot #: E181370, Exp. 5/2020
- Quantity
- 5,424 bottles
- Company
- Hetero Labs, Ltd. - Unit III, Hyderabad
- Distribution
- Indiana and Louisiana
- Initiated
- September 12, 2018 · Voluntary: Firm initiated
- Classified
- September 25, 2018
- Reported
- October 3, 2018
- Ended
- November 29, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fenofibrate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.